Does GEMCITABINE Cause Recurrent cancer? 26 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Recurrent cancer have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.1% of all adverse event reports for GEMCITABINE.
26
Reports of Recurrent cancer with GEMCITABINE
0.1%
of all GEMCITABINE reports
5
Deaths
4
Hospitalizations
How Dangerous Is Recurrent cancer From GEMCITABINE?
Of the 26 reports, 5 (19.2%) resulted in death, 4 (15.4%) required hospitalization, and 5 (19.2%) were considered life-threatening.
Is Recurrent cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 26 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Recurrent cancer?
NIRAPARIB (776)
IMATINIB (237)
CYCLOPHOSPHAMIDE (143)
TRASTUZUMAB (121)
CAPECITABINE (108)
PEMBROLIZUMAB (107)
RITUXIMAB (99)
DOXORUBICIN (97)
OCTREOTIDE (95)
METHOTREXATE (81)
Which GEMCITABINE Alternatives Have Lower Recurrent cancer Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN